EC Number   |
KM Value [mM] |
KM Value Maximum [mM] |
Substrate |
Reference |
|---|
   3.4.21.77 | 0.077 |
- |
Mca-QFYSSNK(epsilon-dinitrophenyl) |
- |
707618 |
| 3.4.21.77 | 0.14 |
- |
4-morpholinecarbonyl-SRKSQQY-7-amido-4-methylcoumarin |
in 50 mM Tris buffer, 0.1 M NaCl, pH 7.8 |
710512 |
| 3.4.21.77 | 0.47 |
- |
HSSKLQ-7-amido-4-methylcoumarin |
- |
707618 |
| 3.4.21.77 | 1.3 |
- |
Lys-Val-Tyr 4-nitroanilide |
- |
647580 |
| 3.4.21.77 | 1.4 |
- |
4-morpholinecarbonyl-HSSKLQ-AMC |
prostate-specific antigen without inhibitor |
701037 |
| 3.4.21.77 | 1.5 |
- |
4-morpholinecarbonyl-HSSKLQ-AMC |
prostate-specific antigen and inhibitor 2-(2-methyl-3-nitrophenyl)-4H-3,1-benzoxazin-4-one (25 micromol) |
701037 |
| 3.4.21.77 | 1.58 |
- |
4-morpholinecarbonyl-HSSKLQ-7-amido-4-methylcoumarin |
pH 7.4, 37°C |
732770 |
| 3.4.21.77 | 1.6 |
- |
4-morpholinecarbonyl-HSSKLQ-AMC |
prostate-specific antigen and inhibitor 2-(2-methyl-3-nitrophenyl)-4H-3,1-benzoxazin-4-one (5 micromol) |
701037 |
| 3.4.21.77 | 1.7 |
- |
Arg-Pro-Tyr 4-nitroanilide |
- |
647580 |
| 3.4.21.77 | 2.6 |
- |
4-morpholinecarbonyl-HSSKLQ-AMC |
prostate-specific antigen and inhibitor (5-amino-3-(pyridin-3-yl)-1H-1,2,4-triazol-1-yl)(4-methoxyphenyl)methanone (5 micromol) |
701037 |
